NCT05044819 2026-03-17
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Jazz Pharmaceuticals
Phase 4 Active not recruiting
Jazz Pharmaceuticals
Boehringer Ingelheim
AstraZeneca
A2 Healthcare Taiwan Corporation
Immunitor LLC
Biotest Pharmaceuticals Corporation